Data on the effectiveness of the artificial intelligence screening system EyeArt was presented at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting in San Francisco. Results of the study examining EyeArt revealed the system had the ability to accurately predict diabetic retinopathy 95.5% of the time, without the input of an ophthalmologist, and in less than a minute. With the diabetes epidemic continuing to plague patient populations in the US and across the globe--and 1 in 4 diabetics developing diabetic retinopathy--investigators sought to evaluate the effectiveness of the artificial intelligence screening system in a group of 893 patients. Led by Srinivas Sadda, MD, of the Doheny Eye Institute at UCLA, investigators conducted the study at 15 different centers across the US. For inclusion in the study, patients needed to have a diagnosis pf diabetes mellitus, be at least 18 years of age, and provide written informed consent.